Drug information for PYLERA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
140MG;125MG;125MG
Prescription
(Reference Drug)
BISMUTH SUBCITRATE POTASSIUM
;
METRONIDAZOLE
;
TETRACYCLINE
Metronidazole
APTALIS PHARMA US
50786
2011-01-24 Letter
2007-05-29 Letter
2007-05-29 Label
2006-11-22 Review
2006-10-02 Letter
Drug Adverse Effects information for PYLERA
Role code
Indications
Reaction
# Reports
PS
HELICOBACTER INFECTION
CLOSTRIDIAL INFECTION
1
Ads by Google